Oncoshot’s cover photo
Oncoshot

Oncoshot

Hospitals and Health Care

Singapore, Singapore 2,901 followers

Made to connect cancer patients, hospitals, and industry with real-time insights.

About us

Oncoshot was founded in 2018 by Medical Oncologist Dr Huren Sivaraj and Data Science Engineer Ruslan Enikeev. As a health insights exchange platform, Oncoshot leverages its proprietary clinical trial matching artificial intelligence technology to address the inefficiencies of cancer clinical trials. The platform serves as a bridge between leading regional healthcare institutions and contract research organizations and global biotechnology and pharmaceutical companies to facilitate data-driven cancer clinical trials while accelerating enrolment into actively recruiting ones.

Industry
Hospitals and Health Care
Company size
11-50 employees
Headquarters
Singapore, Singapore
Type
Privately Held
Founded
2018

Locations

Employees at Oncoshot

Updates

  • Oncoshot reposted this

    The 18th Annual Conference of the Indian Society of Clinical Research (ISCR) brought together global experts and industry leaders to foster AI innovations and the future of Indian clinical trials. It was an honour & a privilege for Oncoshot that our VP, Dr. Nilesh Atre, was invited to speak on the role of AI technology in transforming clinical trial enrolment at Indian clinical trial sites. Dr. Nilesh highlighted that GenAI, LLM and the Well-characterized Repository (WCR) model play a crucial role in revolutionizing the way Indian healthcare systems can work with the global industry players (Big Pharma, CRO, PVG providers, CDM teams, Insurance providers, Regulatory bodies) via their advanced cancer clinical data frameworks. Dr. Huren Sivaraj (CEO) & Dr. Nilesh Atre (VP, Oncoshot) will be visiting Delhi from 19 to 21 Feb. If you would like to collaborate, let’s connect to design strategies to work together.  A big thank you to Indian Society for Clinical Research for hosting this insightful conference and to everyone who participated in the discussion! Pramod Gawli Shekhar Dawkhar Murugananthan Krishnan Dr Arun Bhatt Dr.Seema Pai Dr. Sanish Davis MD, DM,FCP

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
  • Our love and gratitude to everyone working towards better outcomes for our patients. Thank you all. ❤️

    View profile for Huren Sivaraj

    CEO, Oncoshot | Digital Health and Cancer Trials Innovator | Speaker | Oncologist . * I build Cancer Trials Ecosystems, Federated Data Sharing models for National-level stakeholders and Clinical Trials AI products.*

    We’re one day late with the post but remain steadfast in our hopes and wishes for cancer patients. Always. This World Cancer Day 2025, my wish is for a future where cancer care and research ecosystems unite to re-envision a path towards access as a global community—one that embraces rapid technological change, and takes a balanced approach towards both enhancing outcomes for patients today, and inproving early detection to safeguard the health of tomorrow. At Oncoshot, we’re committed to developing the data infrastructure and trust models needed to accelerate this transformation between Healthcare systems and the Life Sciences industy. Happy World Cancer Day, and my sincere gratitude to everyone dedicated to advancing cancer care and research. #worldcancerday #cancer Ruslan Enikeev Chee Yong Chua Dr. Nilesh Atre Andrew Wilson Thanuja Naidu David Chia Shabbir Syed Abdul

    • No alternative text description for this image
  • Improving global access to Precision Oncology. What can we do better? Share your thoughts!

    View profile for Huren Sivaraj

    CEO, Oncoshot | Digital Health and Cancer Trials Innovator | Speaker | Oncologist . * I build Cancer Trials Ecosystems, Federated Data Sharing models for National-level stakeholders and Clinical Trials AI products.*

    Precision Oncology: Is it Time to Reframe the Narrative? A recent Journal of Clinical Oncology review featuring luminaries like Vivek Subbiah, MD and David Thomas outlines the challenges of making precision oncology (PO) globally accessible. As we advance in #Data, #AI, and #Precision Medicine in parallel, I wish for global oncology leadership to reframe this discussion by emphasising the need for timely, high-quality data and evidence as the "Foundation for Progress." Historically, approvals and reimbursement evolved from single biomarker tests (e.g., IHC or PCR) that complemented therapies. While scientific and sensible, the fragmented approval and reimbursement framework lags behind today’s diagnostic efficiencies and the challenges of validating therapies in ever-smaller patient groups. Approval and reimbursement models need to evolve in tandem. And we need Better Data for this transformation. How? 1️⃣ Continuous, Actionable Evidence: Static trial data isn’t enough. Real-world, local data is crucial to inform clinical care and reimbursement decisions and verify that approvals deliver real benefits. Today, technology for such data is no longer an issue. 2️⃣ Robust Infrastructure: Integrate PO into everyday care via secure data systems and applications that promote continuous learning and insights sharing rather than staying confined to research silos and obscure publications. Enable insights sharing within healthcare systems, within a country, and across countries where possible. 3️⃣ Stakeholder Realignment: Real-world and current data can drive more intelligent, adaptive care. To optimise healthcare resource allocation, stakeholders must agree and be ready to reassess decisions tactically on a case-by-case basis and strategically to improve resource distribution for the larger cancer population. Where healthcare systems and regulators must improve: ✅ Scale access to high-quality, clean clinical data: Hospitals need to actively level up deployment of digitisation and data extraction, enrichment, and maintenance processes as a critical first step. Globally, most cancer hospitals cannot effectively and efficiently restructure clinical and biomarker data today! This needs urgent prioritisation. ✅ Leverage scalable and secure data-sharing infrastructure and solutions within research ecosystems: Leverage data to engage the scientific community and payors so that approvals and reimbursement can be more agile in dealing with evolving technologies. Share those insights with research groups globally. The future of PO depends on an integrated approach to data sharing and rapid evidence generation as a foundational priority. We need a shift in mindsets and priorities to change the inequality in access to Precision Oncology. Would a shift in the narrative benefit global oncology? What do you think? #AI #Cancer #PrecisionOncology #RWE Oncoshot Oncoshot India OncoDaily CEO Roundtable on Cancer Union for International Cancer Control (UICC)

    • No alternative text description for this image
  • Oncoshot reposted this

    View profile for Ji Inn Wong

    Regional Director at Singapore Economic Development Board (EDB)

    It's the start of another busy JPM Healthcare Conference week! I'll be speaking at the following events: 1. Navigating Innovation Networks Across Continents, hosted by POM Limburg, moderated by Roeland Buckinx from Health Campus Limburg DC. My fellow panelists are Judyanna Yu from One Six 8 Ventures, Jurie Hwang from KoreaBIO, Ann Van Gysel from MEDVIA and Dave Whelan from Big4Bio. 🕑 Monday 13 Jan, 2pm 📍 The Town Hall by Skylight at 555 California St 2. [Biotech Showcase] Singapore: Launchpad for Life Science Innovation in Asia Pacific, moderated by Sharon Chan from JLABS. I’ll be joined by fellow panelists Matthias Van Woensel from Droia Ventures, Amit Kakar MD from Novo Holdings, Sharon Chen from AlphaLife Sciences and Huren Sivaraj from Oncoshot. 🕓 Tuesday 14 Jan, 4pm 📍 Imperial Ballroom, Hilton Union Square My colleagues at Enterprise Singapore and A*STAR - Agency for Science, Technology and Research are also hosting a Singapore Innovation & Enterprise Showcase 2025, with pitching sessions from Singaporean biotech, medtech and digital health companies, and an exciting panel discussion with Polaris Partners, MPM BioImpact and JLABS (again!). 🕘 Wednesday 15 Jan, 9am - 5pm (panel at 11am) 📍 Marriott Marquis Register here: https://lnkd.in/g5rygwrj Excited to connect with everyone at JPM and share more about Singapore’s innovation ecosystem! Hope to catch you at one of these events or just reach out to me to say hi. Be there or be (Union) Square!

    • No alternative text description for this image
  • For Innovators, Investors and leaders from Healthcare and Life Sciences - insights into the Singapore innovation ecosystem. JLABS Singapore Economic Development Board (EDB) AlphaLife Sciences Novo Holdings Droia Ventures Huren Sivaraj

    View profile for Sharon Chan

    VP JLABS Asia Pacific | Accelerating Healthcare Innovation | Entrepreneurial Leader & Mentor

    Excited to be moderating a discussion on Singapore as a “Launchpad for Life Science Innovation in Asia Pacific" this Tuesday, January 14 at #BiotechShowcase! Singapore’s vibrant and supportive life science ecosystem is emerging as a critical hub for biomedical innovation in the Asia Pacific region, fostering opportunities for groundbreaking partnerships, R&D, and business growth. This is a conversation you don’t want to miss with Ji Inn Wong of Singapore Economic Development Board (EDB), Sharon Chen of AlphaLife Sciences, Huren Sivaraj of Oncoshot, Matthias Van Woensel of Droia Ventures, and Amit Kakar MD of Novo Holdings as we share our insights on building up and standing out in the region and beyond. Looking forward to connecting with innovators and leaders driving life sciences forward on a global scale. Let’s shape the future of health together! https://lnkd.in/g-TTENnp #JLABS #JPM25 #JPM2025

    • No alternative text description for this image
  • Oncoshot reposted this

    Meet the startups behind Singapore's emerging innovations. Join us at the Singapore Innovation & Enterprise Showcase taking place on 15 January 2025, at the San Francisco Marriott Marquis during the J.P. Morgan Annual Healthcare Conference week. This event will showcase Singapore’s most innovative #startups and offer a unique opportunity for innovators, entrepreneurs, and investors to connect, collaborate, and exchange ideas. Plus, join our panel discussion on Singapore's biomedical ecosystem and opportunities in Asia-Pacific, with Amy Schulman of Polaris Partners, Ansbert Gadicke of MPM BioImpact, Alessandro Falcone of JLABS Singapore, Hugo Saavedra of KYAN Technologies, and Irene Cheong of A*STAR - Agency for Science, Technology and Research. Register now: https://lnkd.in/gUZCM_Th Learn more about presenting startups: https://lnkd.in/gZbzHdm2 Ananda Immunotherapies | AUM Biosciences | Avecris | Axcynsis Therapeutics | BioSyngen | BluMaiden Biosciences | ImmunoScape | Nuevocor | PairX Bio | Paratus Sciences | Tikva Allocell Pte Ltd | VerImmune | Auristone Pte Ltd | BioCheetah Pte Ltd | KYAN Technologies | Lucence | Qritive | Nousq Pte Ltd | Vivo Surgical | Aevice Health | Biorithm | Mesh Bio | Oncoshot | CoNEX Healthcare | Respiree

  • Oncoshot reposted this

    View profile for Huren Sivaraj

    CEO, Oncoshot | Digital Health and Cancer Trials Innovator | Speaker | Oncologist . * I build Cancer Trials Ecosystems, Federated Data Sharing models for National-level stakeholders and Clinical Trials AI products.*

    AI in Healthcare: Unlocking the Future of SaaS Some of you might have caught the viral video about Microsoft’s CEO Satya Nadella voicing, “SaaS is dead,”. For healthcare, however, it’s not about the end of SaaS but its evolution. Cloud-delivered software is being transformed by AI, offering exciting opportunities to improve clinical care, research, and hospital operations. Why Healthcare Hesitates with SaaS Healthcare systems, especially public institutions and the vast majority in APAC and EU, have traditionally been cautious about adopting SaaS. Concerns around data privacy, security, and compliance with regulations like GDPR and HIPAA have slowed adoption. However, healthcare-compliant cloud infrastructure has matured over the last several years. These systems can now meet the industry’s strict standards while enabling secure, scalable innovation. AI and SaaS: A Smarter Partnership AI doesn’t replace SaaS; it supercharges it. Instead of static dashboards or rigid workflows, AI makes systems more dynamic and useful. For example in Oncoshot’s use cases of Clinical trials and RWE: ✅Clinicians can ask AI to find eligible patients for trials or analyze real-world survival data in a natural language query as opposed to getting their IT team to get those insight. ✅Administrators can uncover operational inefficiencies and differences prescribing behavior and outcomes. While challenges like cost and compute resources remain depending on the applications, AI-driven SaaS promises smarter, adaptive systems that respond to real-world needs. The Logic Layer: Making AI Reliable The foundation of this transformation is the logic layer. This ensures data isn’t just stored but organized and enriched for meaningful use. It plays a critical role by: 👍Validating AI results to avoid errors or hallucinations. 👍Structuring raw data into actionable insights. At Oncoshot, tools like OS-EXTA, OS-ENRA, and OS-MAIA help build this layer within hospital-controlled cloud environments. These tools structure clinical and operational data, creating a reliable foundation for AI to thrive responsibly. The Future of AI in Healthcare With the convergence of AI and healthcare-compliant infrastructure, we are entering an era where technology evolves from being a tool to becoming a trusted partner. From improving patient care to driving research, the potential is transformative. Exciting times for healthcare systems and the life sciences industry! Oncoshot Oncoshot India Ruslan Enikeev Chee Yong Chua Dr. Nilesh Atre Andrew Wilson David Chia Thanuja Naidu Shabbir Syed Abdul

    • No alternative text description for this image
    • No alternative text description for this image
  • Oncoshot reposted this

    View profile for Huren Sivaraj

    CEO, Oncoshot | Digital Health and Cancer Trials Innovator | Speaker | Oncologist . * I build Cancer Trials Ecosystems, Federated Data Sharing models for National-level stakeholders and Clinical Trials AI products.*

    Next week, I’ll be in San Francisco during one of healthcare’s most influential gatherings, the JP Morgan Healthcare Conference #JPM2025. This year, AI in Healthcare and Life Sciences will continue to take center stage, and Oncoshot is proud to be part of the conversation. As Asia's leading health insights exchange platform, we're tackling the most complex data challenges in oncology through the power of advanced technologies. Our solutions leverage data extraction automation and oncology fine-tuned LLMs to empower cancer centres with streamlined data management, foster stronger collaborations between healthcare systems and industry, and connect patients with cutting-edge clinical trials and research. If you’re interested in exploring collaborations, let’s connect in person in San Francisco next week! #JPM2025 #OncologyResearch #AIinHealthcare #ClinicalInnovation #FutureOfHealthcare Ruslan Enikeev Chee Yong Chua Dr. Nilesh Atre Andrew Wilson Yigit Yucel Oncoshot Oncoshot India Enterprise Singapore JLABS Nicole A. Pang Xue Bin Derek Neo Alessandro Falcone, MD Ronne Yeo Kenneth Goh Anvesh Ramineni Cheryl Teo

    • No alternative text description for this image
  • Oncoshot reposted this

    View profile for Huren Sivaraj

    CEO, Oncoshot | Digital Health and Cancer Trials Innovator | Speaker | Oncologist . * I build Cancer Trials Ecosystems, Federated Data Sharing models for National-level stakeholders and Clinical Trials AI products.*

    2024 - Drenched, tired and a tad crazy. But we're all still smiling :) As 2024 comes to a close, I’m reflecting on a year of resilience and progress for Oncoshot. Despite the challenging climate for startups, we’ve made significant financial and operational strides. More than ever, I'm confident in Oncoshot’s vision and impact as we lay the groundwork for a future where oncology research is efficient, cost-effective, and near-realtime health data sharing between healthcare systems and innovators can be a reality. Some highlights from this year: 1. Empowering Hospitals with Better Data This year, we strengthened our value proposition for hospitals with technologies for automated data extraction and restructuring of clinical data. By addressing long-standing barriers to entry (ie manpower to restructure data), we’ve made it easier for hospitals to manage research data effectively. Starting in APAC, this approach is now gaining traction with hospital partners in US, UK, and EU, underscoring the global demand for better systems. The coming 6 mths will be focused on executing data pipelines for 3 large health system partners globally. 2. Strengthening Industry Collaboration We proudly launched Singapore’s first industry-supported tumor registry, proving how public-private partnerships can unlock new opportunities and reshape oncology research. I'm excited about how we are collectively building new models of #RWE consumption with more real-time aggregate insights sharing. While we look to bring more industry partners to participate in the ongoing projects in Singapore, we are also in the midst of strategising new projects with the same innovative industry partners across other health systems outside SG. 3. Innovating for the Future, Today. A major milestone this year was the launch of RecommendTx, our oncology-tuned LLM solution that matches cancer patients with clinical trials. In the coming year, we will be doubling down on our fine-tuned LLM model to expand its capabilities across RWE - expanding the power of our LLM and to deploy this LLM locally in a cost efficient model. We are delighted to partner with the likes of Amazon Web Services (AWS) as a public sector partner to make our LLM available in a federated and affordable manner for our hospitals. As I reflect, I am deeply grateful to everyone who has been part of this journey. Your support has been critical in empowering our vision to transform cancer data and research. Here’s to 2025—a year of more innovation, collaboration, and breakthroughs. Wishing you all a Happy New Year! 🎉 #Innovation #Oncology #Collaboration #NewYear2025 #Healthcare   Oncoshot Oncoshot India Ruslan Enikeev Chee Yong Chua Dr. Nilesh Atre Andrew Wilson Thanuja Naidu Yigit Yucel

    • No alternative text description for this image
    • No alternative text description for this image
  • Oncoshot reposted this

    View profile for Huren Sivaraj

    CEO, Oncoshot | Digital Health and Cancer Trials Innovator | Speaker | Oncologist . * I build Cancer Trials Ecosystems, Federated Data Sharing models for National-level stakeholders and Clinical Trials AI products.*

    Harnessing AI to Transform Clinical Development It was great to have participated in the "Harnessing AI and Digital Technology to Accelerate Clinical Development" panel discussion at #JLABS Singapore two weeks ago. James Gallagher, Head of Early Innovation at Johnson & Johnson, provided a clear and compelling overview of how AI is transforming clinical trials—from smarter design to enhanced patient recruitment. A/Prof Danny Soon, CEO of Consortium for Clinical Research and Innovation, Singapore (CRIS) and Singapore Clinical Research Institute (SCRI), shared public sector insights on drivers of progress in Singapore’s clinical research ecosystem. Sharon Chen, CEO of AlphaLife Sciences, shared examples on how #GenAI is revolutionizing clinical workflows for biopharma, highlighting the rapid innovation in this space to improve efficiency.. I had the chance to discuss how AI can enable trusted and efficient extraction and management of healthcare data to support clinical development. There’s still much to be done on the data front—ensuring accessibility, quality, and readiness to truly unlock AI’s full potential. That said, we’re at a remarkable point in time, with immense opportunities to collaborate and advance clinical development like never before. A big thank you to Alessandro Falcone, MD, Head JLABS Singapore, and Sharon Chan, VP JLABS APAC, for organizing such a dynamic and impactful event. Bringing together public and private stakeholders, pharma, and startups is exactly what’s needed to drive innovation and deliver better outcomes for patients. Excited for what’s next! #AIinHealthcare #ClinicalInnovation Oncoshot #JLABSSingapore #Collaboration #DigitalHealth #ClinicalTrials #PharmaInnovation Kenneth Goh Ran Tao Sravanthy Manesh Ruslan Enikeev Chee Yong Chua Yigit Yucel Germaine L Megan Chu Mei Kan Dr. Nilesh Atre Andrew Wilson Shabbir Syed Abdul Zubin Daruwalla Bernard Ng Simon Hopkins

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image

Affiliated pages

Similar pages

Funding

Oncoshot 5 total rounds

Last Round

Seed

US$ 900.0K

See more info on crunchbase